01—Abstract
Summary
Summary of the 10-Q filed August 7, 2008. Cited figures are marked; the original filing is the authoritative source.
CME Group Inc. reported strong revenue growth in the second quarter and first six months of 2008, driven primarily by an increase in clearing and transaction fees, significantly boosted by the inclusion of CBOT (Chicago Board of Trade) products following their merger in July 2007.
Total revenues surged by 71%a and 80% respectively for the quarter and year-to-date periods compared to the prior year. This growth was supported by increased trading volumes across various asset classes, including equity and foreign exchange, spurred by market volatility related to the credit crisis and inflationary expectations. Expenses also rose, largely due to integration costs, higher compensation and benefits, and increased amortization of acquired intangibles.
Despite rising expenses, the company maintained a strong operating margin. Financially, CME Group ended the period with substantial cash and cash equivalents. The company is actively pursuing a significant strategic acquisition of NYMEX Holdings, Inc., which is expected to close in the third quarter of 2008, and has secured substantial bridge financing to support this transaction.
Additionally, a new share buyback program and a special dividend were announced, indicating a focus on returning capital to shareholders. The company's financial position remains robust, though it faces ongoing integration efforts and strategic growth initiatives.
02—Key points
Key Highlights
- Total revenues increased significantly by 71% for the quarter and 80% for the six-month period ended June 30, 2008, compared to the same periods in 2007, largely due to the inclusion of CBOT revenues and strong trading volumes.
- Clearing and transaction fees saw substantial growth, increasing by 81% and 92% for the quarter and six months respectively, driven by higher trading volumes and an increased average rate per contract.
- Equity product trading volume experienced a significant surge (31% for the quarter, 48% for the six months) due to increased market volatility, while foreign exchange products also saw robust growth (26% for the quarter, 21% for the six months).
- Operating expenses increased by 61% and 66% for the quarter and six months respectively, reflecting increased compensation and benefits, higher amortization of purchased intangibles, and depreciation and amortization costs related to the CBOT merger.
- The company ended the period with $1.07 billion in cash and cash equivalents, providing significant liquidity.
- CME Group is proceeding with the acquisition of NYMEX Holdings, Inc., expected to close in Q3 2008, and has secured a $3.2 billion bridge financing commitment.
- A new share buyback program of up to $1.1 billion and a special dividend of $5.00 per common share were announced, signaling a commitment to shareholder returns.
03—One dollar
04—Financials
Financial Highlights
Figures from 10-QQ2 FY2008filed August 7, 2008Financial Statements
| Revenue | $563.20M |
| Operating Expenses | $219.50M |
| Operating Income | $343.70M |
| Net Income | $201.20M |
| EPS (Basic) | $0.74 |
| EPS (Diluted) | $0.73 |
| Shares Outstanding (Basic) | 272.50M |
| Shares Outstanding (Diluted) | 273.76M |
05—Questions
Frequently Asked Questions
What are the primary drivers behind CME Group's revenue growth in this period?
The primary drivers of revenue growth were the inclusion of CBOT's results following the merger in July 2007, significantly increasing trading volumes and clearing/transaction fees. Additionally, increased market volatility, driven by the credit crisis and inflationary concerns, boosted trading volumes in equity and foreign exchange products.
How is the pending acquisition of NYMEX Holdings expected to impact CME Group?
The acquisition of NYMEX Holdings, expected to close in Q3 2008, is a major strategic initiative aimed at expanding CME Group's product offerings and market reach. The transaction involves a mix of cash and stock, with significant bridge financing arranged to fund the cash component. This acquisition is expected to create a larger, more diversified derivatives marketplace.
What is the company's approach to shareholder returns given its financial performance and strategic plans?
CME Group announced a significant share buyback program of up to $1.1 billion and a special dividend of $5.00 per common share, signaling a strong commitment to returning capital to shareholders. These actions are supported by the company's robust cash flow generation and strategic positioning.
Are there any significant legal proceedings or contingent liabilities that investors should be aware of?
The company is involved in several legal proceedings, including a class-action lawsuit related to the NYMEX merger, and ongoing antitrust litigation. Additionally, there's a contingent liability related to the CBOE Exercise Right Privileges (ERPs) with a potential maximum payment of $293.0 million. While the company believes these matters will not have a material adverse effect, they represent potential financial exposures.
06—Continue